The older a surgeon gets, the lower the patient mortality rate, with female surgeons in their 50s having the lowest rates overall, according to research led by Yusuke Tsugawa, MD, MPH, PhD, assistant professor at the University of California, Los Angeles.

Radiologists or technologists who manually select protocols for commonly ordered exams rarely add value, making protocol selection a prime target for workflow automation, according to recent research.

Fewer quality measures, a shorter reporting period for Meaningful Use requirements and an increase in uncompensated rate payments were all positives in the eyes of hospitals in their initial reaction to the proposed 2019 Medicare Inpatient Prospective Payment System (IPPS) rule.

Lab-created consciousness, especially resulting from testing human brain tissue, sounds like the plot for the newest binge-worthy TV show, but it’s a matter worth consideration from an ethical perspective, according to some experts. A group of 17 researchers examined issues that may arise as scientists get closer to replicating human brain functions.

Mobile health (mHealth) applications for clinical decision support could improve physicians' test ordering and diagnosis decisions, according to a study published April 20 in the Journal of Informatics in Health and Biomedicine.

Researchers at the University of Pennsylvania School of Medicine have identified a novel biomarker—as well as a way to image that biomarker non-invasively—for PARP inhibitors in women with ovarian cancer.

FDA Commissioner Scott Gottlieb, MD, said his administration is working on an updated “new regulatory framework” to promote the use of artificial intelligence (AI) in healthcare, and he expects medical imaging to be at the forefront of AI-based healthcare devices, according to a report published by The Hill.

False-positive results from a breast or prostate cancer exam could be driving affected men and women to adhere to clinical testing guidelines, researchers wrote in a Cancer study—though a handful of false-positive patients are actually deterred from future screenings.